BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15266506)

  • 1. Inhaled insulin in diabetes mellitus.
    Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
    Cochrane Database Syst Rev; 2004; (3):CD003890. PubMed ID: 15266506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled insulin in diabetes mellitus.
    Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
    Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Inhaled insulin in diabetes mellitus.
    Royle P; Waugh N; Deakin M; Philip S
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003890. PubMed ID: 19160227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
    Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003287. PubMed ID: 15495047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
    Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
    Cochrane Database Syst Rev; 2004; (2):CD003287. PubMed ID: 15106199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis.
    Pittas AG; Westcott GP; Balk EM
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
    Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.
    Vos RC; van Avendonk MJ; Jansen H; Goudswaard AN; van den Donk M; Gorter K; Kerssen A; Rutten GE
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006992. PubMed ID: 27640062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.
    Black C; Cummins E; Royle P; Philip S; Waugh N
    Health Technol Assess; 2007 Sep; 11(33):1-126. PubMed ID: 17767897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
    Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
    Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.